Link Fund Solutions
Latest statistics and disclosures from Link Fund Solutions's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Amr, and represent % of Link Fund Solutions's stock portfolio.
- Added to shares of these 1 stock: Amr.
- Started 1 new stock position in Amr.
- Reduced shares in these 2 stocks: Theravance Biopharma (-$111M), Evofem Biosciences (-$46M).
- Sold out of its positions in Evofem Biosciences, Theravance Biopharma.
- Link Fund Solutions was a net seller of stock by $-157M.
- Central Index Key (CIK): 0001792424
Tip: Access up to 7 years of quarterly data
Positions held by Link Fund Solutions consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Link Fund Solutions
Link Fund Solutions holds 1 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Amr | 0.0 | $0 | NEW | 0 | 0.00 |
|
Past Filings by Link Fund Solutions
SEC 13F filings are viewable for Link Fund Solutions going back to 2019
- Link Fund Solutions 2020 Q2 filed July 7, 2020
- Link Fund Solutions 2020 Q1 filed April 16, 2020
- Link Fund Solutions 2019 Q4 filed Jan. 28, 2020